Maternal delivery of a MuSK agonist antibody reveals a novel strategy for understanding and treating early-onset neuromuscular diseases.
Congenital myasthenia (CM) comprises a group of neuromuscular diseases caused by mutations in genes responsible for the formation and function of neuromuscular synapses, including genes encoding neuronal Agrin, low-density receptor-related protein 4 (Lrp4), muscle-specific kinase (MuSK), downstream of kinase 7 (Dok7),...